These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24615996)

  • 21. The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice.
    Petruzziello-Pellegrini TN; Yuen DA; Page AV; Patel S; Soltyk AM; Matouk CC; Wong DK; Turgeon PJ; Fish JE; Ho JJ; Steer BM; Khajoee V; Tigdi J; Lee WL; Motto DG; Advani A; Gilbert RE; Karumanchi SA; Robinson LA; Tarr PI; Liles WC; Brunton JL; Marsden PA
    J Clin Invest; 2012 Feb; 122(2):759-76. PubMed ID: 22232208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of CXCR4 and CXCR7 Is Protective in Acute Peritoneal Inflammation.
    Ngamsri KC; Jans C; Putri RA; Schindler K; Gamper-Tsigaras J; Eggstein C; Köhler D; Konrad FM
    Front Immunol; 2020; 11():407. PubMed ID: 32210974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. α
    Albee LJ; Eby JM; Tripathi A; LaPorte HM; Gao X; Volkman BF; Gaponenko V; Majetschak M
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
    Nazari A; Khorramdelazad H; Hassanshahi G
    Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A study of CXCR4/SDF-1 in hepatocellular carcinoma and liver cirrhosis].
    Shi GY; Shi DJ; Lü WB; Chen YK; Tong XM
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):276-8. PubMed ID: 17456315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.
    Inaguma S; Riku M; Ito H; Tsunoda T; Ikeda H; Kasai K
    Oncotarget; 2015 Oct; 6(32):33648-57. PubMed ID: 26413813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells.
    Mazzinghi B; Ronconi E; Lazzeri E; Sagrinati C; Ballerini L; Angelotti ML; Parente E; Mancina R; Netti GS; Becherucci F; Gacci M; Carini M; Gesualdo L; Rotondi M; Maggi E; Lasagni L; Serio M; Romagnani S; Romagnani P
    J Exp Med; 2008 Feb; 205(2):479-90. PubMed ID: 18268039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relevance of the CXCR4/CXCR7-CXCL12 axis and its effect in pathophysiological conditions.
    Huynh C; Dingemanse J; Meyer Zu Schwabedissen HE; Sidharta PN
    Pharmacol Res; 2020 Nov; 161():105092. PubMed ID: 32758634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signaling properties of the human chemokine receptors CXCR4 and CXCR7 by cellular electric impedance measurements.
    Doijen J; Van Loy T; De Haes W; Landuyt B; Luyten W; Schoofs L; Schols D
    PLoS One; 2017; 12(9):e0185354. PubMed ID: 28945785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Split Gaussia luciferase for imaging ligand-receptor binding.
    Luker KE; Luker GD
    Methods Mol Biol; 2014; 1098():59-69. PubMed ID: 24166368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR7 heterodimerizes with CXCR4 and regulates CXCL12-mediated G protein signaling.
    Levoye A; Balabanian K; Baleux F; Bachelerie F; Lagane B
    Blood; 2009 Jun; 113(24):6085-93. PubMed ID: 19380869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.
    Cheng YH; Eby JM; LaPorte HM; Volkman BF; Majetschak M
    PLoS One; 2017; 12(11):e0187949. PubMed ID: 29125867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3.
    Murphy PM; Heusinkveld L
    Cytokine; 2018 Sep; 109():2-10. PubMed ID: 29398278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CXCL12 receptor preference, signal transduction, biological response and the expression of 5T4 oncofoetal glycoprotein.
    McGinn OJ; Marinov G; Sawan S; Stern PL
    J Cell Sci; 2012 Nov; 125(Pt 22):5467-78. PubMed ID: 22956548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of an interaction between TGF-β1 and the SDF-1/CXCR4/CXCR7 axis in human platelets.
    Rath D; Chatterjee M; Holtkamp A; Tekath N; Borst O; Vogel S; Müller K; Gawaz M; Geisler T
    Thromb Res; 2016 Aug; 144():79-84. PubMed ID: 27314628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CXCR4 and CXCR7 form a functional receptor unit for SDF-1/CXCL12 in primary rodent microglia.
    Lipfert J; Ödemis V; Wagner DC; Boltze J; Engele J
    Neuropathol Appl Neurobiol; 2013 Oct; 39(6):667-80. PubMed ID: 23289420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease.
    Werner L; Elad H; Brazowski E; Tulchinsky H; Vigodman S; Kopylov U; Halpern Z; Guzner-Gur H; Dotan I
    J Leukoc Biol; 2011 Sep; 90(3):583-90. PubMed ID: 21628333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemokines: potent mediators of hepatic inflammation and fibrosis in chronic liver diseases.
    Handa P; Kowdley KV
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):152-4. PubMed ID: 24378280
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.